ROZA BROWN: Open Payments
NPI 1902464639 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 12 payments from 10 companies in 2025. Trend: 2023 $134 · 2024 $32 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 2 | $59 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| Innovation Technologies Inc | 1 | $32 |
| Smith+Nephew, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Solventum Corporation | 1 | $23 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Elucent Medical | 1 | $18 |
| PolyNovo North America LLC | 1 | $15 |
Products named: PURAPLY WOUND MATRIX, JOURNAVX, IRRISEPT, COLLAGENASE SANTYL, Magtrace, KEYTRUDA, V.A.C. VERAFLO, GORE ENFORM Preperitoneal Biomaterial.
Industry payments across AR — which companies pay providers there.
